US OptionsDetailed Quotes

ESPR250117P5000

Watchlist

0.05
0.000.00%

15min DelayClose Jan 17 16:00 ET

0.00High0.00Low

Esperion Therapeutics Stock Discussion

Roadto1Mil

16 hours ago

$Esperion Therapeutics (ESPR.US)$ is it going to rocket?

10xStockPicks

17 hours ago

Esperion Therapeutics Is Take Over Target Offering 10x Upside. 8 Analysts Expect 500% Upside

$Esperion Therapeutics (ESPR.US)$Three Analysts Place Strong BUY Ratings on Esperion Therapeutics, Targeting $7, $9, and $16 per Share; Acquisition by Big Pharma Likely
Esperion Therapeutics (ESPR), currently priced around $2 per share, is gaining significant attention from analysts, with three experts placing strong BUY ratings on the stock and price targets ranging from $7 to $16. The company, known for ...

10xStockPicks

Jan 23 07:47

Today 3 Analysts Place BUY Ratings On This $2 Stock $7,$9 & $16 Which Is An Acquisition Target by BIG Pharma

$Esperion Therapeutics (ESPR.US)$ Jan 23, 2025 Three analysts are bullish on Esperion Therapeutics with price targets on this $2 stock ranging from $7 to $16 a share.
Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...

DazzlerAus

Jan 23 06:08

price targets $7 to $9

$Esperion Therapeutics (ESPR.US)$ lets hope these guys are right

Hatt bosdike

Jan 22 14:53

$Esperion Therapeutics (ESPR.US)$ strong accumilations happening here in these price ranges. upside move is going to be good 🚀🚀

Youngman

Jan 22 14:09

$Esperion Therapeutics (ESPR.US)$ here we go guys! 🙂

Roadto1Mil

Jan 22 01:44

$Esperion Therapeutics (ESPR.US)$ will it rocket today?

Youngman

Jan 19 12:59

$Esperion Therapeutics (ESPR.US)$ This may pop after the 22nd 😉

10xStockPicks

Jan 15 09:18

Esperion Therapeutics Is An Extreme Bargain Now With A Recently New $8 Price Target Strong Buy Rating Is 300% Upside Reward.

$Esperion Therapeutics (ESPR.US)$ The current stock price doesn't justify the incredible growth prospects this company has. Esperion sells the only FDA labeled Statin alternative drugs with primary prevention labels, script growth is growing rapidly and Esperion will be profitable in 2025 with expected $0.25 per share in earnings and $0.70c per share in 2026, which makes E...

103459086 : i am betting the house on this stock. hopefully the market recognises its potential and rerates the stock. hard to stomach when other crap stocks go up based on hot air alone.

Report
Reply

Cancel Reply
DazzlerAus : Agree it's a bargin

Report
Reply

Cancel Reply
73372627 : Keep for you looser

Report
Reply

Cancel Reply
RoNo : BoFA has a sell rating with a 2.05 price target. What do you see?

Report
Reply

Cancel Reply
PhotoSynth : This is a KLAC discussion board. Get the hell off the board and stop hawking your moon shots by spamming a barage of other boards, completely ignoring community integrity , ignoring the reality that when people go to a community group to check sentiment for a given stock, not only do you annoy those that are there for the right reasons, but your cavalier behavior also puts at risk the new inexperienced trader, who in this case has been led to a very high quality stock like KLAC, only to find at the top of the list a stock thats completely unrelated, only to potentially be lured away from study of a good stock, by someone grifting prophecy on a single stock that could quite literally wipe out a new trader in a matter of a few weeks or even days, all because they haven’t quite yet been able to dispell the belief that all comments on stocks are reasonably equivalent in merit, …… because as we know,…. they are not. Nor do they necessarily understand that not all investors have the same goals or risk tolerance levels…….
What a crappy way to show the lack of integrity of your self serving actions on unrelated boards………. Not to mention, like it or not,…it really pisses me off!……If you must “hawk” a stock, please keep your hawking solely within the confines of the related stock’s discussion board….
. ….. Thanks.

Report
Reply

Cancel Reply

View more comments...

Hatt bosdike

Jan 10 12:47

$Esperion Therapeutics (ESPR.US)$ nice consolidation on these levels. There is confluence of support at the same levels and look at that big volume spike just few days back at the same level. Big money is not letting thd price go down below this level. Hold and keep accumilating. Spike is coming soon. 🤞

No comment yet